04:55 PM EDT, 03/16/2026 (MT Newswires) -- Veracyte ( VCYT ) appointed Kevin Haas to the new role of chief development and technology officer, effective March 24.
Haas, 40, was previously chief technology officer at Myriad Genetics ( MYGN ) , Veracyte ( VCYT ) said Monday in a regulatory filing.